1100 related articles for article (PubMed ID: 16181204)
1. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention.
Denomme GA; Wagner FF; Fernandes BJ; Li W; Flegel WA
Transfusion; 2005 Oct; 45(10):1554-60. PubMed ID: 16181204
[TBL] [Abstract][Full Text] [Related]
2. Do we need to be more concerned about weak D antigens?
Garratty G
Transfusion; 2005 Oct; 45(10):1547-51. PubMed ID: 16181202
[No Abstract] [Full Text] [Related]
3. Novel weak D types 31 and 32: adsorption-elution-supported D antigen analysis and comparison to prevalent weak D types.
Körmöczi GF; Förstemann E; Gabriel C; Mayr WR; Schönitzer D; Gassner C
Transfusion; 2005 Oct; 45(10):1574-80. PubMed ID: 16181207
[TBL] [Abstract][Full Text] [Related]
4. Weak D type 1.1 exemplifies another complexity in weak D genotyping.
Doescher A; Flegel WA; Petershofen EK; Bauerfeind U; Wagner FF
Transfusion; 2005 Oct; 45(10):1568-73. PubMed ID: 16181206
[TBL] [Abstract][Full Text] [Related]
5. Rh discrepancies caused by variable reactivity of partial and weak D types with different serologic techniques.
Denomme GA; Dake LR; Vilensky D; Ramyar L; Judd WJ
Transfusion; 2008 Mar; 48(3):473-8. PubMed ID: 18067505
[TBL] [Abstract][Full Text] [Related]
6. Secondary anti-D immunization by Del red blood cells.
Yasuda H; Ohto H; Sakuma S; Ishikawa Y
Transfusion; 2005 Oct; 45(10):1581-4. PubMed ID: 16181208
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization.
Körmöczi GF; Gassner C; Shao CP; Uchikawa M; Legler TJ
Transfusion; 2005 Oct; 45(10):1561-7. PubMed ID: 16181205
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetics of RH and its clinical application.
Flegel WA
Transfus Clin Biol; 2006; 13(1-2):4-12. PubMed ID: 16563832
[TBL] [Abstract][Full Text] [Related]
9. Weak D phenotypes and transfusion safety: where do we stand in daily practice?
Noizat-Pirenne F; Verdier M; Lejealle A; Mercadier A; Bonin P; Peltier-Pujol F; Fialaire-Legendre A; Tournamille C; Bierling P; Ansart-Pirenne H
Transfusion; 2007 Sep; 47(9):1616-20. PubMed ID: 17725725
[TBL] [Abstract][Full Text] [Related]
10. The genomic organization of the partial D category DVa: the presence of a new partial D associated with the DVa phenotype.
Omi T; Takahashi J; Tsudo N; Okuda H; Iwamoto S; Tanaka M; Seno T; Tani Y; Kajii E
Biochem Biophys Res Commun; 1999 Jan; 254(3):786-94. PubMed ID: 9920819
[TBL] [Abstract][Full Text] [Related]
11. Identification of RHD alleles with the potential of anti-D immunization among seemingly D- blood donors in Upper Austria.
Polin H; Danzer M; Gaszner W; Broda D; St-Louis M; Pröll J; Hofer K; Gabriel C
Transfusion; 2009 Apr; 49(4):676-81. PubMed ID: 19170995
[TBL] [Abstract][Full Text] [Related]
12. [Foetomaternal erythrocyte incompatibilities: from immunohaematologic surveillance of pregnant women to haemolytic disease of the newborn].
Miquel E; Cavelier B; Bonneau JC; Rouger P
Transfus Clin Biol; 2005 Feb; 12(1):45-55. PubMed ID: 15814293
[TBL] [Abstract][Full Text] [Related]
13. Molecular biology of partial D and weak D: implications for blood bank practice.
Flegel WA; Wagner FF
Clin Lab; 2002; 48(1-2):53-9. PubMed ID: 11833677
[TBL] [Abstract][Full Text] [Related]
14. Serologic and molecular characterization of D variants in Brazilians: impact for typing and transfusion strategy.
Credidio DC; Pellegrino J; Castilho L
Immunohematology; 2011; 27(1):6-11. PubMed ID: 22356480
[TBL] [Abstract][Full Text] [Related]
15. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ
Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461
[TBL] [Abstract][Full Text] [Related]
16. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
Zavala C; Salamanca F
Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
[TBL] [Abstract][Full Text] [Related]
17. RHD alleles among pregnant women with serologic discrepant weak D phenotypes from a multiethnic population and risk of alloimmunization.
Bub CB; Aravechia MG; Costa TH; Kutner JM; Castilho L
J Clin Lab Anal; 2018 Jan; 32(1):. PubMed ID: 28374955
[TBL] [Abstract][Full Text] [Related]
18. Serologic and molecular investigations of DAR1 (weak D Type 4.2), DAR1.2, DAR1.3, DAR2 (DARE), and DARA.
Lejon Crottet S; Haer-Wigman L; Gowland P; Fontana S; Niederhauser C; Hustinx H
Transfusion; 2013 Nov; 53(11 Suppl 2):3000-8. PubMed ID: 23902153
[TBL] [Abstract][Full Text] [Related]
19. Effective molecular RHD typing strategy for blood donations.
Polin H; Danzer M; Hofer K; Gassner W; Gabriel C
Transfusion; 2007 Aug; 47(8):1350-5. PubMed ID: 17655577
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of RHD alleles in Argentineans with variant D phenotypes.
Brajovich ME; Boggione CT; Biondi CS; Racca AL; Tarragó M; Nogués N; Muñiz-Díaz E; Cotorruelo CM
Transfusion; 2012 Feb; 52(2):389-96. PubMed ID: 21883261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
